Screener/Healthcare/Biotechnology

ANTX

AN2 Therapeutics, Inc.NASDAQ
$3.72-0.11 (-2.87%)
$1.00
$6.91
$3.44
$3.82
EPS (TTM)$-1.12
P/E Ratio
Dividend Yield
Market Cap$143.9M
Volume402K
Prev Close$3.83
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q3 '25$0-$9.4M$-0.31
Q2 '25$0-$6.5M$-0.21
Q1 '25$0-$10.6M$-0.35
Q4 '24$0-$7.5M$-0.25
Q3 '24$0-$12.7M$-0.43
Q2 '24$0-$14.4M$-0.48
Q1 '24$0-$16.6M$-0.56
Q4 '23$0-$16.9M$-0.52
Get Your Daily Market Recap